Cytosolic Ca2+ levels and arachidonate liberation were investigated in platelets loaded with the fluorescent Ca2+ indicator dye fura-2, and labelled with [3H]arachidonate. Fura-2 was used in preference to quin2 because the latter interfered with [3H]arachidonate labelling of phospholipids. Pi. This phosphatidate formation was decreased (75%) by the presence of indomethacin. 6. In the presence of indomethacin, phorbol myristate acetate (20 nM) alone or in combination with ionomycin (30 nM) failed to stimulate arachidonate liberation despite a marked stimulation of aggregation. 7. These results indicate that, whereas ionomycin requires Ca2+ in the ,uM range for arachidonate liberation, collagen, notably in the presence of indomethacin, does so at basal Ca2+ levels. The mechanisms underlying the regulation ofarachidonate release by collagen are not clear, but do not appear to involve activation of protein kinase C, or an elevation of cytosolic free Ca2 .
INTRODUCTION
In response to certain physiological or pharmacological stimuli many different cell types synthesize and release by exocytosis one or more of the biologically active lipids that are derived from arachidonic acid. These lipids, collectively known as eicosanoids (Corey et al., 1980) , include prostaglandins, thromboxanes and leukotrienes. Because the intracellular level of free arachidonate is low in most cells, the rate-determining step in eicosanoid biosynthesis is usually the liberation of free arachidonate from glycerolipids (for review see Irvine, 1982) .
The mechanisms underlying arachidonic acid liberation in platelets have been extensively investigated. In these cells arachidonic acid is predominantly found esterified in the sn-2 position ofmembrane phospholipids, particularly PtdCho, PtdEtn and Ptdlns. Four major routes for arachidonate liberation have been proposed: (i) direct deacylation of phospholipids by a phospholipase (PL) A2 type enzyme (McKean et al., 1981) ; (ii) deacylation by a PLA1 activity followed by a lysophospholipase; (iii) sequential activation of phosphoinositide-specific PLC followed by diacylglycerol lipase (Mauco et al., 1978; Rittenhouse-Simmons, 1979; Bell et al., 1979) ; (iv) phosphatidate-specific PLA2 following phosphoinositidespecific PLC/diacylglycerol kinase .
Phospholipases of the A2 type have been considered to be Ca2+-calmodulin-dependent and as such susceptible to activation following an increase in [Ca2+] , (Wong & Cheung, 1979 ; but see also Withnall et al., 1984; Ballou & Cheung, 1985) . In contrast, activation of phosphoinositide-specific PLC as a consequence of specific agonistreceptor interactions is Ca2+-independent and results in the generation of intracellular second messengers including an elevation in [Ca2+] , (Berridge, 1984) which may then activate Ca2+-calmodulin-dependent processes. These inositide-specific reactions may be relevant to receptor-mediated liberation of free arachidonate as proposed in routes (iii) and (iv) above; the question remains, however, as to whether receptor occupation itself, or a subsequent elevation in [Ca2+] 1, is the controlling factor in evoking free arachidonate liberation.
Activation of blood platelets by collagen results in stimulation ofphosphoinositide metabolism (Lloyd et al., However, both these biochemical and functional responses are markedly attenuated by cyclo-oxygenase blockade with aspirin o-r indomethacin, indicating a pivotol role for TxA2 in mediating these effects ofcollagen. Thromboxane receptors on human platelets are coupled to stimulation of phospho-inositide metabolism and an elevation in [Ca2+] , (Pollock et al., 1984) and so it is likely that many of the biochemical responses observed in response to collagen are mediated by prostaglandin endoperoxides and/or TxA2 (Siess et al., 1983) . Thus the paradox remains as to how the free arachidonate necessary for TxA2 synthesis is liberated during the initial plateletcollagen interaction.
To what extent PLA or PLC are regulated by Ca2+ has been confused by the examination of these enzymes under non-physiological conditions using 'artificial' substrates and/or 'artificial' environments (for a discussion of these, see for example Irvine et al., 1984a) . The development of the fluorescent Ca2+ indicator dye quin2 (Tsien et al., 1982) has allowed [Ca2+] , measurements in intact platelets at rest or during stimulation by agonists (Tsien et al., 1984) . Recently a novel fluorescent Ca2+-indicator dye, fura-2, has been developed by Tsien and colleagues (Grynkiewicz et al., 1985) . Fura-2 exhibits much greater fluorescence than quin2 and so it may be used at much lower loading concentrations in the cell.
Using fura-2-loaded platelets to monitor [Ca2+], we have investigated the regulation of arachidonate liberation in response to collagen and the Ca2+ ionophore ionomycin. In the present paper we present evidence to suggest a differential Ca2+-sensitivity for the liberation of arachidonate in human platelets in response to these two agonists.
EXPERIMENTAL

Materials
Soluble collagen reagent (Horm) was from Malin Medical Supplies, Alloway, Scotland, U.K.; ionomycin (Calbiochem), fura-2 acetoxymethyl ester (a gift from Dr Roger Tsien, University of California, Berkeley, CA, U.S.A. or from Molecular Probes, Junction City, OR, U.S.A.), PMA (Sigma) and digitonin (BDH) were dissolved in dimethyl sulphoxide. Indomethacin (Sigma) was dissolved at a concentration of 10 mm in methanol. Lipid standards were prepared from yeast and pig liver; PtdA was prepared from yeast PtdCho by PLD activity from a cauliflower extract (Dawson & Hemington, 1967) . All other laboratory reagents and solvents were of analytical grade. T.l.c. plates (Merck silica gel 60 F-254 precoated glass plates) were from Camlab, Cambridge, U.K. [5,6,8,9,11,12,14,15-3H] Arachidonic acid Ci/mmol) and carrier-free [32P]P, were from Amersham International, Amersham, Bucks, U.K.
Preparations of cells
Blood was obtained by venepuncture from healthy human volunteers, who denied taking aspirin in the previous 10 days, and was mixed with one-sixth volume of acid citrate dextrose (2.5 g of sodium citrate, 1.5 g of citric acid and 2 g of D-glucose in 100 ml of water). This blood was then centrifuged (700 g, 5 min 15-20°C) and the supernatant (platelet-rich plasma) aspirated into plastic tubes. Plasma-free suspensions of platelets were then prepared by centrifugation (350 g, 20 min, 15-20°C) of the platelet-rich plasma in the presence of 20 ,tg of apyrase/ml, discarding the supernatant, and resuspending the cells in physiological saline (145 mM-NaCl, 5 mm-KCl, 1 mM-MgSO4, 10 mM-Hepes and 10 mM-glucose, pH 7.4 at 37°C) at 3 x 108 cells/ml. The platelet suspension was then incubated for 45 min at 37°C in the presence of 1 /,M of the membrane-permeant fura-2 acetoxymethyl ester and 2 #Ci of [3H]arachidonic acid/ml. In fura-2-loaded platelets the maximum fluorescence (Fmax ) is equivalent to 3 times the cell autofluorescence when the loading concentration offura-2 is 30 /LM (T. J. Rink & R. Y. Tsien, unpublished work). The fura-2 loading concentration using the above protocol was calculated to be 20-30 ,umol/litre of cell water. In some experiments 20 ,#Ci of [32P]P1 was also present. After loading and labelling, the pH of the cell suspension was adjusted to < 6.5 by the addition of 0.2% (v/v) acid citrate dextrose. Platelets were then pelleted by centrifugation (350 g, 20 min, 15-20°C) in the presence of 20 ,g of apyrase/ml, resuspended in fresh buffer at (1.5-2) x 108 cells/ml and stored at room temperature in a stoppered-plastic tube until use. In preliminary experiments to determine the effect ofquin2 loading on [3H]arachidonate incorporation, platelet-rich plasma was incubated with 2 ,uCi of
[3H]arachidonic acid/ml in the absence (control) or presence (quin2 loading) of 15 4uM-quin2 acetoxymethyl ester, for 30 min at 37 'C. These conditions give 1-1.5 mM internal quin2.
Experimental protocol Aliquots (0.8 ml) of cells were dispensed into round bottom test tubes and the external Ca2+ ([Ca2+]0) concentration adjusted to 1 mm with CaCl2. These samples were then transferred to a purpose-built cuvette holder and thermostatted at 37 'C in a Perkin-Elmer MPF 44A spectrophotometer which allowed simultaneous measurement of fluorescence and absorbance. The cell suspension was continuously stirred with a magnetic follower so that platelet shape change/aggregation could be monitored turbidimetrically. Following equilibration at 37 'C for at least 5 min, agonists were added to the platelets as indicated. At the appropriate time after agonist addition the reaction was stopped by the addition of 1 ml of ice-cold methanol to the cells and the entire sample was transferred by plastic pipette to a Pyrex test tube on ice. Within any one experiment duplicate or triplicate determinations of each agonist addition were carried out. To minimize time-dependent effects on platelet responsiveness, leakage ofthe dye or redistribution of radiolabel, experiments were designed to be completed within 45 min-I h.
Measurement of cytosolic free calcium levels
In an analogous manner to quin2, fura-2 is liberated from its methyl ester by cytosolic esterases inside the cell. Upon binding of Ca2+, fura-2 undergoes both a change in fluorescence intensity and a spectral shift (Grynkiewicz et al., 1985) . For our purposes fura-2 fluorescence was monitored continuously using monochromator settings of 339 nm (excitation) and 500 nm (emission). The [Ca2+], levels were calculated using the general formula
where Kd is the dissociation constant for Ca2+ binding to the indicator and F is arbitrary fluorescent units. For fura-2, Kd = 224 nM (Grynkiewicz et al., 1985) . Fmax was determined by lysing the cells with 50 /LM-digitonin, thus exposing the fura-2 to 1 mM-Ca2+. Fmin was determined by adjusting the pH of the lysed cells to 8.5 wlith 20mM-Tris base followed by the addition of 10 mM-EGTA. Under these conditions, the Kd for Ca2+-EGTA is < 10-9 M. Alternatively, by quenching the fluorescence with 2 mM-Mn2+ to give the autofluorescence (AF) of the cells, Fmin can be calculated from the relationship between Fmax Fmin and AF as derived from the emission spectra of Ca2+-saturated and Ca2+-free dye (Grynkiewicz et al., 1985; Tsien et al., 1985) . For our spectrophotometer, using glass cuvettes at the monochromator settings used, we calculated this relationship to be:
Fmin. = AF+ (Fmax-AF)/3.7
Lipid analyses
Lipids were extracted essentially according to Bligh & Dyer (1959) by the addition of 1.5 ml of chloroform/ methanol (2: 1, v/v) plus 20 ,1 of 10 M-HCI to the quenched platelets. After vortex-mixing, the aqueous and organic phases were partitioned by the addition of 1 ml of chloroform, followed by 1 ml of water, and separated by centrifugation (1000 g for 5 min). The organic (lower) phase was removed into a glass test tube with a pasteur pipette and dried down at 40°C under a stream of N2.
Separation by t.l.c.
Major phospholipids and free fatty acids, including arachidonate, were separated by one-dimensional t.l.c. using a system modified from that of Irvine et al. (1984b) . T.l.c. plates were sprayed with 1 mM-EDTA (adjusted to pH 5.5 with NaOH) until saturated, and were then activated for 1 h at 160°C in an oven. The lipids were resuspended to 100 ,1 in chloroform/methanol (9: 1, v/v) and spotted, using a Hamilton syringe, as 1.5 cm bands 1.5 cm from the bottom of the plate. To facilitate visualization of the lipids with iodine, 5-10 ,ug of carrier Ptdlns, PtdA and oleic acid were added to each lipid sample. The t.l.c. plates were developed in one dimension for 1 h using a solvent of chloroform/methanol/water/ acetic acid (65: 50: 5: 2, by vol.) until the solvent front was 12-14 cm from the origin. Individual lipids were visualized by exposure of the plate to iodine vapour and identified by co-migration with lipid standards. This separation resolved PtdCho, PtdSer, Ptdlns, PtdA, PtdEtn and free fatty acids including arachidonate. Silica corresponding to these lipids was scraped into a 4 ml plastic scintillation vial containing 3.5 ml of scintillation fluid and the samples were counted in a liquid-scintillation spectrometer.
Statistical analysis of results
Results with P values of *P < 0.05, **P < 0.01 and ***p < 0.001.
RESULTS
Effect of qwin2 and fura-2 on I3Hlarachidonate incorporation At the commencement of our studies we had at our disposal both quin2 and fura-2 acetoxy methyl esters. In view of several reports of toxic effects of quin2 (Rink & Pozzan, 1985) regard to the effects of ionomycin and collagen showed that fura-2 loading has no effect on the phenomena shown in this paper (see below for details). Whatever the mechanisms for the differences between fura-2 and quin2, we assume that these result from the much lower loading used with fura-2, although we have not specifically investigated this possibility. Fura-2 certainly appears to have significant advantages over quin2 for our investigative purposes and was therefore used in all our studies. Fig.   3(b) indicate that the platelets undergo shape change 10-20 s after collagen addition, and this is rapidly followed by platelet aggregation. The onset ofaggregation causes a problem when monitoring fluorescence changes, because the formation ofplatelet aggregates quenches the fluorescence signal. Hence, although the declining phase of the fluorescence record in Fig. 3(b) could in part initially reflect Ca2+ sequestration/extrusion, the rapidly oscillating decline in the signal is mostly due to quenching [Ca2]i (#M) Fig. 2 collagen (10 jug/ml) in the presence of 10 1uM-indomethacin, added 5 min prior to the agonist, were made as described for Fig. 1 Fig. 2 where the correlation between [Ca2+1] and free [3H]arachidonate accumulation in response to collagen/ indomethacin is illustrated. The data for collagen in the absence of indomethacin are not included in Fig. 2 because of the uncertainty in determining the maximum [Ca2+], in aggregating platelets as discussed above. Fig. 2 (Blackwell et al., 1977; Irvine, 1982) .
As seen in Table 2 Lipids from the platelet samples shown in Fig. 3 were analysed as described in the Experimental section and for (Holmsen et al., 1981) . The results from an experiment similar to that depicted in Fig. 3 (Rink et al., 1983) an effect of PMA that has been attributed to the activation of protein kinase C. We have investigated whether PMA Representative fluorescence and absorbance traces from fura-2-loaded platelets stimulated as described for Fig. 4 are shown.
arachidonate levels in Fig. 4 . A low concentration of ionomycin failed to stimulate phosphoinositide turnover via PLC activation (indicated by [32P]PtdA formation) as seen in Table 3 . This effect is consistent with the concept that PLC activation in platelets is dependent upon occupation of receptors (Rittenhouse, 1984) . In contrast with the immediate elevation in [Ca2+]1 produced by ionomycin, the elevation in [Ca2+] , produced by collagen was preceded by a 10-20 s lag phase. Such an observation in fura-2-loaded platelets is consistent with the pattern of [Ca2+]1 changes produced by collagen in quin2-loaded platelets (Rink & Hallam, 1984) . From the studies with indomethacin shown in Fig. 3 , the elevation in [Ca2+] , in response to collagen appears to be almost totally dependent on cyclo-oxygenase products. Prostaglandin endoperoxides and TxA2 are known to interact with TxA2 receptors on the platelet plasma membrane that are coupled to an elevation in [Ca2+], (Pollock et al., 1984) .
The results summarized in Fig. 2 indicate that collagen initiates the liberation of free arachidonate both in the absence and in the presence of indomethacin at [Ca2+] , levels at which ionomycin-induced elevation of [Ca2+] , is ineffective. Therefore, collagen appears to use mechanisms additional to or independent of [Ca2+]1. In the absence of indomethacin, the 20% depletion in PtdCho caused by collagen (Table 2) can more than account for the complementary increase in [3H]arachidonate, suggesting that deacylation of this phospholipid is the principal source of free arachidonate during platelet activation. However, we should emphasize that these remarks apply only to the radiolabelled acid; previous studies on platelets have shown clear differences between mass and radiolabelling data (Blackwell et al., 1977; Irvine, 1982) , and probably deacylation of PtdEtn is occurring also in the present experiments. (Irvine & Dawson, 1979; Kramer & Deykin, 1983) .
To what extent collagen-platelet interaction per se contributes to the effects on platelet lipids, and to what extent these effects are dependent upon the generation of prostaglandin endoperoxides and TxA2, can be assessed (Table 3) indicates that collagen itself may activate PLC. These results are in agreement with Sano et al. (1983) , but contradictory to the results of Siess et al. (1983) who found no stimulation of [32P]PtdA formation by collagen in the presence of indomethacin. However the recent report of InsP3 accumulation in indomethacin-treated platelets stimulated with collagen (Watson et al., 1985) supports the probability that collagen-platelet interaction directly activates PLC. Previous studies have considered direct deacylation of phospholipids to be a consequence of Ca2+-calmodulindependent activation of PLA2 (Pickett et al., 1977; Wong & Cheung, 1978) . However collagen fails to elevate [Ca2+] , sufficiently to activate the enzyme by this means.
It is known that oleoyl acetyl glycerol can shift the Ca2+-dependency curve for platelet dense granule secretion to the left (Knight & Scrutton, 1984) . Recently evidence from neutrophils (Volpi et al., 1985) has shown that PMA, presumably by mimicking endogenouslyproduced diacylglycerol to activate protein kinase C, acts synergistically with ionomycin to stimulate arachidonate liberation. The negative results obtained with PMA in the presence of ionomycin (Fig. 4) would suggest that such a mechanism for the activation of PLA2 may not exist in human platelets. Mobley & Tai (1985) have observed synergism between ionomycin and PMA for TxB2 formation, whilst Halenda et al. (1985) have demonstrated an enhancement, by PMA, of arachidonate liberation by A23187. However, both these groups found that high concentrations of PMA and/or calcium ionophores were required. Their data suggest that the concentrationresponse curve for PMA in the presence of ionophore, or vice versa, with respect to liberating arachidonic acid is to the right of the concentration response curves in inducing platelet aggregation.
Thus the results of Mobley & Tai (1985) and Halenda et al. (1985) are not inconsistent with ours, and our data (Fig. 4) emphasize that the ability of collagen to induce diacylglycerol production, and therefore activate protein kinase C, does not explain its efficacy in stimulating phospholipid deacylation. A more plausible mechanism for regulating arachidonate liberation in response to collagen at low [Ca2+] , is membrane perturbation (Dawson, 1982; Irvine, 1982; Dawson et al., 1984) . Stress-induced deacylation may result from macromolecular collagen fibrils binding to several sites on the platelet plasma membrane causing lateral strain across the membrane surface. In mast cells, liberation of arachidonate by compound 48/80 may also involve membrane perturbation activation ofPLA2 (Okano et al., 1985) .
In the absence ofindomethacin, the role ofarachidonate metabolites (prostaglandin endoperoxides and TxA2) in platelet responses to collagen may be simplistically assessed as a mechanism to reinforce the effects of collagen. The thromboxane-dependent elevation in [Ca2+] i and the stimulation of phosphoinositide turnover as a consequence of TxA2 receptor occupancy may have a more important role to play in the regulation of the biochemical pathways concerned with platelet shape, change and aggregation rather than with arachidonate liberation per se (compare the synergism between PMA and ionomycin for platelet aggregation but not with arachidonate liberation). It has been suggested that metabolites of arachidonate exhibit positive co-operativity with collagen to regulate the liberation of arachidonate itself (Rittenhouse-Simmons & Allen, 1982) . Hence, although collagen-platelet adhesion causes the initial deacylation, subsequent synthesis of eicosanoids may further contribute to this process. The thromboxane dependentelevation in [Ca2+]i also indicates a fundamental difference between TxA2 receptors and collagen binding sites on platelets. Whereas the former are coupled to stimulation of Ca2+ influx, the latter would not appear to be so.
In conclusion, we have demonstrated that collagen can induce the liberation of free arachidonate at, or near, resting [Ca2+]1, and the mechanism of this activation remains to be investigated.
